Evidence map›Paper›PMID 30286730›Full record

ArticleBMC nephrology2018

High cut-off membrane for in-vivo dialysis of free plasma hemoglobin in a patient with massive hemolysis.

David Cucchiari, Enric Reverter, Miquel Blasco, Alicia Molina-Andujar, Adriá Carpio, Miquel Sanz, Angels Escorsell, Javier Fernández, Esteban Poch

Open access · goldAbstract readCase Reports
In one paragraph

Article in BMC nephrology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
1.8field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 7 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

David CucchiariNephrology and Renal Transplant Unit, Hospital Clínic, Carrer Villaroel 170, 08036, Barcelona, Spain. david.cucchiari@gmail.com.ORCID 0000-0002-7594-1070
Enric ReverterLiver Intensive Care Unit, Hepatology. Hospital Clínic, Barcelona, Spain.
Miquel BlascoNephrology and Renal Transplant Unit, Hospital Clínic, Carrer Villaroel 170, 08036, Barcelona, Spain.
Alicia Molina-AndujarNephrology and Renal Transplant Unit, Hospital Clínic, Carrer Villaroel 170, 08036, Barcelona, Spain.
Adriá CarpioLiver Intensive Care Unit, Hepatology. Hospital Clínic, Barcelona, Spain.
Miquel SanzLiver Intensive Care Unit, Hepatology. Hospital Clínic, Barcelona, Spain.
Angels EscorsellLiver Intensive Care Unit, Hepatology. Hospital Clínic, Barcelona, Spain.
Javier FernándezLiver Intensive Care Unit, Hepatology. Hospital Clínic, Barcelona, Spain.
Esteban PochNephrology and Renal Transplant Unit, Hospital Clínic, Carrer Villaroel 170, 08036, Barcelona, Spain.
Hospital Clínic de Barcelona · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe possibility of clearing Cell-free Plasma Hemoglobin (CPH) from human plasma may appear attractive, especially when considering the noxious effects that CPH has on the immune function and the renal damage caused by its filtration. The existence of the so-called High Cut-Off (HCO) filters, possessing pores as big as 60 kDa, could potentially allow the clearance of the αβ dimers (31.3 kDa), the form in which the α2β2 hemoglobin tetramers (62.6 kDa) physiologically dissociate in plasma. We present herein the first reported case in which such an attempt was made. CASE PRESENTATION: The patient was a 51-year-old man with hemolytic crisis due to glucose-6-phosphate dehydrogenase deficiency, further complicated by pigment-induced nephropathy. He underwent a 48-h CVVHD session, in which a HCO filter was used. The Sieving Coefficient (SC) for CPH was initially 0.08 and decreased to 0.02 after 24 h. This unexpected low SC was due to the initial high concentration of CPH (4.24 g/L). At such concentrations, the α2β2 tetramer poorly dissociates into the αβ dimer; but increases exponentially at concentrations lower than 1 g/L.

conclusionsClearance of CPH through a HCO filter is technically feasible but its performance markedly relies on the initial concentration of CPH. Critically ill patients with smoldering hemolysis, as it happens during septic shock or ECMO treatment, may benefit the most from the use of this membrane in order to clear CPH.

Indexed as

HemolysisAcute Kidney InjuryGlucosephosphate Dehydrogenase DeficiencyHemofiltrationHemoglobinsHepatitis AHumansMaleMiddle AgedRenal DialysisHemoglobinsAcute kidney injuryContinuous renal replacement therapyFree hemoglobinHigh-cut off filterSepsis

Identifiers

PMID30286730
PMCPMC6172805
OpenAlexW2895348788

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.